Skip to content

Clinical trials

Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Completed Country / region: Sweden Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20071
20081
20093
20121
20132
20152
20171
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Rigshospitalet, Denmark3
Amgen2
Bristol-Myers Squibb2
Birgitte Klug Albertsen1
European Organisation for Research and Treatment of Cancer - EORTC1
Janssen Research & Development, LLC1
Lund University Hospital1
Nordic Society for Pediatric Hematology and Oncology1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma18
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Recurrence3
Leukemia, Myeloid, Accelerated Phase2
Leukemia, Myeloid, Acute2
Neoplasms2
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Embryonal1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.